-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Bimekizumab is a unique molecule with a dual mechanism of action.
This is a new type of humanized monoclonal IgG1 antibody that can potently and selectively neutralize IL-17A and IL-17F, which are two types of driving the inflammatory process Key cytokines
.
IL-17A and IL-17F have similar pro-inflammatory functions, and independently cooperate with other inflammatory mediators to drive chronic inflammation and damage in multiple tissues
.
Leave a message here